Intranasal Etripamil For Conversion of Paroxysmal Supraventricular Tachycardia

 

PSVT Node-1 Trial: Intranasal Etripamil For Conversion of Paroxysmal Supraventricular Tachycardia (PSVT) Node-1 Trial.

Interview with Bruce Stambler from Piedmont Heart Institute, Atlanta, Georgia, USA at HRS 2017.